Flunarizine
- Generic Name
- Flunarizine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26F2N2
- CAS Number
- 52468-60-7
- Unique Ingredient Identifier
- R7PLA2DM0J
- Background
Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Indication
Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
- Associated Conditions
- Severe Migraine
- Associated Therapies
- -
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
- Conditions
- Interventions
- First Posted Date
- 2024-07-12
- Last Posted Date
- 2024-07-12
- Target Recruit Count
- 460
- Registration Number
- NCT06499116
Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Target Recruit Count
- 600
- Registration Number
- NCT04702971
- Locations
- 🇨🇳
Headache Center, Teipei Veterans General Hospital, Taipei, Taiwan
Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Ataturk University
- Target Recruit Count
- 120
- Registration Number
- NCT03712917
- Locations
- 🇹🇷
Ataturk University Resarch Hospital, Erzurum, Turkey
Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis
- First Posted Date
- 2015-12-24
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Taipei Veterans General Hospital, Taiwan
- Target Recruit Count
- 62
- Registration Number
- NCT02639598
Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol
- Conditions
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2008-08-22
- Lead Sponsor
- Ambulatório de Bipolaridade
- Target Recruit Count
- 70
- Registration Number
- NCT00740259
- Locations
- 🇧🇷
Universidade Federal de São Paulo, São Paulo, SP, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.